{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T09:06:23Z","timestamp":1789031183830,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,3]],"date-time":"2027-09-03T00:00:00Z","timestamp":1819929600000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.tips.2026.07.009","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T04:38:38Z","timestamp":1786336718000},"page":"955-958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Amyloidogenic amylin signaling links diabetes to dementia pathogenesis"],"prefix":"10.1016","volume":"47","author":[{"given":"Florin","family":"Despa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammaryn","family":"Lashley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.07.009_bb0005","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2026.07.009_bb0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s42255-026-01465-4","article-title":"The story of amylin: from physiology to therapy","volume":"8","author":"Secher","year":"2026","journal-title":"Nat. Metab."},{"key":"10.1016\/j.tips.2026.07.009_bb0015","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/bph.13496","article-title":"Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development","volume":"173","author":"Bower","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tips.2026.07.009_bb0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tips.2026.07.009_bb0025","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2026.07.009_bb0030","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ajpath.2014.11.016","article-title":"In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease","volume":"185","author":"Oskarsson","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tips.2026.07.009_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3233\/JAD-160047","article-title":"Intraneuronal amylin deposition, peroxidative membrane injury and increased IL-1\u03b2 synthesis in brains of Alzheimer\u2019s disease patients with type-2 diabetes and in diabetic HIP rats","volume":"53","author":"Verma","year":"2016","journal-title":"J. Alzheimer's Dis"},{"key":"10.1016\/j.tips.2026.07.009_bb0040","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1177\/0271678X16657093","article-title":"Amylin alters human brain pericyte viability and NG2 expression","volume":"37","author":"Schultz","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.tips.2026.07.009_bb0045","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ana.24992","article-title":"Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia","volume":"82","author":"Ly","year":"2017","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2026.07.009_bb0050","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.25570","article-title":"Amylin as a potential link between type 2 diabetes and alzheimer disease","volume":"86","author":"Martinez-Valbuena","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2026.07.009_bb0055","article-title":"The association of circulating amylin with \u03b2-amyloid in familial Alzheimer\u2019s disease","volume":"N. Y.) 7","author":"Ly","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tips.2026.07.009_bb0060","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s42003-022-04398-2","article-title":"Abeta efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas","volume":"6","author":"Verma","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.tips.2026.07.009_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104682","article-title":"Rapid, scalable assay of amylin-beta amyloid co-aggregation in brain tissue and blood","volume":"299","author":"Kotiya","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2026.07.009_bb0070","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1096\/fj.201700431R","article-title":"Amyloid-beta and islet amyloid pathologies link Alzheimer\u2019s disease and type 2 diabetes in a transgenic model","volume":"31","author":"Wijesekara","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2026.07.009_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2026.115157","article-title":"Peripheral amylin modulation rebalances brain glycolysis and Tau-Ser214 phosphorylation via cAMP-PKA signaling","volume":"29","author":"Davargaon","year":"2026","journal-title":"iScience"},{"key":"10.1016\/j.tips.2026.07.009_bb0080","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1038\/s41593-023-01377-6","article-title":"Heart failure-induced cognitive dysfunction is mediated by intracellular Ca2+ leak through ryanodine receptor type 2","volume":"26","author":"Dridi","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2026.07.009_bb0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/cm.21822","article-title":"Tau and Alzheimer\u2019s disease: past, present and future","volume":"81","author":"Iqbal","year":"2024","journal-title":"Cytoskeleton (Hoboken)"},{"key":"10.1016\/j.tips.2026.07.009_bb0090","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1007\/s12035-021-02490-y","article-title":"Genetic depletion of amylin\/calcitonin receptors improves memory and learning in transgenic Alzheimer\u2019s disease mouse models","volume":"58","author":"Patel","year":"2021","journal-title":"Mol. Neurobiol."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726001781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726001781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T08:10:23Z","timestamp":1789027823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614726001781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0165614726001781"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.07.009","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amyloidogenic amylin signaling links diabetes to dementia pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}